Vaxcyte PCVX
NASDAQ PCVX
$56.90 +0.21 (+0.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Cash from Financing Activities (2019 - 2026)

Updated

Vaxcyte's Cash from Financing Activities was $5.7 million in Q2 2026, up 126.4% from $2.52 million a year earlier but down 99.1% from the prior quarter.

Analysis

Vaxcyte (PCVX) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vaxcyte's Cash from Financing Activities was $606.02 million through Jun 30, 2026, down 60.2% year-over-year; for FY2025, it was $2.01 million, down 99.9% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -64.8% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $2.45 billion in FY2024 (+282.7%), $639.81 million in FY2023 (-25.7%), $861.55 million in FY2022 and $17.8 million in FY2021 (-95.3%).
  • Quarterly Cash from Financing Activities has moved between -$3.67 million (Q3 2025) and $1.52 billion (Q3 2024) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in two of the last five quarters, with an average decline of 8.5%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2023 (growth of 996.6%); the worst was Q1 2025 (a decline of 99.9%).
  • Per Business Quant data, PCVX's Cash from Financing Activities in the three quarters before Q2 2026 was $601.58 million (Q1 2026), $2.41 million (Q4 2025) and -$3.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Vaxcyte 8.24 Bn 8.24 Bn - 5.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.70 Mn
Mar 31, 2026 601.58 Mn
Dec 31, 2025 2.41 Mn
Sep 30, 2025 -3.67 Mn
Jun 30, 2025 2.52 Mn
Mar 31, 2025 759,000.00
Dec 31, 2024 4.91 Mn
Sep 30, 2024 1.52 Bn
Jun 30, 2024 110.37 Mn
Mar 31, 2024 818.20 Mn
Dec 31, 2023 2.74 Mn
Sep 30, 2023 48.55 Mn
Jun 30, 2023 546.97 Mn
Mar 31, 2023 41.56 Mn
Dec 31, 2022 656.63 Mn
Sep 30, 2022 44.02 Mn
Jun 30, 2022 49.88 Mn
Mar 31, 2022 111.02 Mn
Dec 31, 2021 8.75 Mn
Sep 30, 2021 7.60 Mn
API Access

Vaxcyte Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PCVX&period=max&api_key=YOUR_API_KEY